img
img
NEW ONSET ATRIAL FIBRILLATION DUE TO AMPHETAMINE USE IN A YOUNG PATIENT    
Yazarlar (2)
Dr. Öğr. Üyesi Muammer KARAKAYALI Dr. Öğr. Üyesi Muammer KARAKAYALI
Kafkas Üniversitesi, Türkiye
Timor Omar
Kafkas Üniversitesi, Türkiye
Devamını Göster
Özet
The Food and Drug Administration (FDA) label for amphetamine gives warning of serious cardiovascular events and risk of sudden death in patients with structural heart disease or other serious cardiac conditions. Literature review was unrevealing for linkage of amphetamine stimulants to atrial fibrillation specifically. Additionally, recreational use of amphetamines can cause electrical instability of the myocardium potentially leading to arrhythmias, although this is more typical in the setting of an underlying structural heart defect. We must rely on the diligence of the practitioner to evaluate all possible causes for a new onset arrhythmia, and possibly specifically ask about the off label use of these medications. There is clear documentation in the literature regarding myocardial infarction, stroke, and sudden death in adults using CNS stimulants. However, there is little data regarding specific arrhythmias, including atrial …
Anahtar Kelimeler
Makale Türü Diğer (Teknik, not, yorum, vaka takdimi, editöre mektup, özet, kitap krıtiği, araştırma notu, bilirkişi raporu ve benzeri)
Makale Alt Türü Diğer hakemli ulusal dergilerde yayınlanan teknik not, editöre mektup, tartışma, vaka takdimi ve özet türünden makale
Dergi Adı Sabuncuoglu Serefeddin Health Science (SSHS)
Dergi ISSN 2667-6338
Makale Dili İngilizce
Basım Tarihi 02-2021
Cilt No 3
Sayı 1
Sayfalar 45 / 49
Makale Linki https://dergipark.org.tr/tr/download/article-file/1508059
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları

Paylaş